#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	3164	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2519	373.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1662	1662	C	436	C,T	378,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5164	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3803	406.7	0	.	n	.	0	T695C	SNP	695	695	T	1146	1146	C	402	C,T	350,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5164	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3803	406.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1788	1788	A	448	A	407	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5164	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3803	406.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2422	2422	C	477	C,T	407,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5164	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3803	406.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2496	2496	A	503	A	426	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5164	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3803	406.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3048	3048	C	459	C	402	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	4	blaTEM	861	552	99.46	blaTEM.l15.c30.ctg.1	771	1.2	0	.	p	.	0	L38F	NONSYN	112	114	TTG	331	333	TTT	1;1;1	T;T;T	1;1;1	.	Betalactam resistance
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	4	blaTEM	861	552	99.46	blaTEM.l15.c30.ctg.1	771	1.2	0	.	p	.	0	F70L	NONSYN	208	210	TTT	427	429	TTA	1;1;1	T;T;A,T	1;1;0,1	.	Betalactam resistance
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	4	blaTEM	861	552	99.46	blaTEM.l15.c30.ctg.1	771	1.2	0	.	p	.	0	V117L	NONSYN	349	351	GTA	568	570	TTA	1;1;1	T,G;T;A	0,1;1;1	.	Betalactam resistance
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	526	folP	852	852	100.0	folP.l15.c4.ctg.1	1858	85.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1174	1176	AGC	136;139;140	A;G;C	116;117;117	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1104	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3743	88.4	1	SNP	p	S91F	0	.	.	271	273	TCC	780	782	TCC	115;115;115	T;C;C	96;97;97	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1104	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3743	88.4	1	SNP	p	D95G	0	.	.	283	285	GAC	792	794	GAC	111;110;110	G;A;C	93;93;94	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1104	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3743	88.4	1	SNP	p	D95N	0	.	.	283	285	GAC	792	794	GAC	111;110;110	G;A;C	93;93;94	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.Neisseria_meningitidis_H44_76_v1_00513	mtrR.Neisseria_meningitidis_H44_76_v1_00513	1	1	531	394	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1654	71.4	0	.	p	.	0	L20fs	FSHIFT	58	58	T	560	560	T	112	T	96	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	170	mtrR_promoter	250	193	96.37	mtrR_promoter.l15.c4.ctg.1	1453	35.1	0	.	n	.	0	A125G	SNP	125	125	A	842	842	G	74	G	54	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	170	mtrR_promoter	250	193	96.37	mtrR_promoter.l15.c4.ctg.1	1453	35.1	0	.	n	.	0	C147T	SNP	147	147	C	864	864	T	65	T	50	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	170	mtrR_promoter	250	193	96.37	mtrR_promoter.l15.c4.ctg.1	1453	35.1	0	.	n	.	0	T159C	SNP	159	159	T	876	876	C	68	C	53	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	170	mtrR_promoter	250	193	96.37	mtrR_promoter.l15.c4.ctg.1	1453	35.1	0	.	n	.	0	C189T	SNP	189	189	C	906	906	T	59	T	54	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	170	mtrR_promoter	250	193	96.37	mtrR_promoter.l15.c4.ctg.1	1453	35.1	0	.	n	.	0	A192T	SNP	192	192	A	909	909	T	59	T	53	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	170	mtrR_promoter	250	193	96.37	mtrR_promoter.l15.c4.ctg.1	1453	35.1	0	.	n	.	0	A195C	SNP	195	195	A	912	912	C	59	C	52	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	170	mtrR_promoter	250	193	96.37	mtrR_promoter.l15.c4.ctg.1	1453	35.1	0	.	n	.	0	G221A	SNP	221	221	G	938	938	A	56	A	54	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1164	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3271	106.9	1	SNP	p	D86N	0	.	.	256	258	GAC	719	721	GAC	123;124;125	G,C;A,C;C	106,1;107,1;110	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1164	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3271	106.9	1	SNP	p	S87I	0	.	.	259	261	AGT	722	724	AGT	126;126;126	A;G;T	109;110;108	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1164	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3271	106.9	1	SNP	p	S87R	0	.	.	259	261	AGT	722	724	AGT	126;126;126	A;G;T	109;110;108	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1164	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3271	106.9	1	SNP	p	S87W	0	.	.	259	261	AGT	722	724	AGT	126;126;126	A;G;T	109;110;108	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1164	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3271	106.9	1	SNP	p	S88P	0	.	.	262	264	TCC	725	727	TCC	126;127;125	T;C;C	109;111;108	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	966	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3023	96.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1768	1770	GGC	128;127;126	G,T;G;C	109,1;107;109	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	828	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2690	92.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1399	1401	GCA	109;108;107	G;C;A,C	100;100;99,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	828	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2690	92.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1402	1404	ATC	107;107;108	A,C;T;C	99,1;98;100	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	828	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2690	92.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1414	1416	GTG	110;110;110	G;T;G	102;101;101	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	828	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2690	92.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1414	1416	GTG	110;110;110	G;T;G	102;101;101	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	828	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2690	92.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1918	1920	ACC	103;103;103	A,C;C,A;C	89,1;88,1;90	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	828	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2690	92.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1972	1974	GCG	104;104;104	G;C;G	90;81;88	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	828	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2690	92.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1972	1974	GCG	104;104;104	G;C;G	90;81;88	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	828	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2690	92.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2095	2097	GGC	111;110;110	G;G;C	100;101;101	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	828	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2690	92.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2104	2106	GGC	110;110;110	G;G;C	98;102;101	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	828	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2690	92.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2122	2124	CCG	111;111;111	C,G;C;G,A	88,1;100;95,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1124	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3302	102.1	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1742	1744	CTG	98;98;98	C;T;G	84;84;85	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	518	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2178	71.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	760	760	C	104	C	87	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	27	650	porB1b	1047	1047	100.0	porB1b.l6.c30.ctg.1	2000	96.9	1	SNP	p	G120K	0	.	.	358	360	GGC	809	811	GGC	142;140;140	G,A;G;C	116,1;116;116	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	27	650	porB1b	1047	1047	100.0	porB1b.l6.c30.ctg.1	2000	96.9	1	SNP	p	A121D	1	.	.	361	363	GAC	812	814	GAC	142;143;144	G;A;C	119;120;122	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	27	650	porB1b	1047	1047	100.0	porB1b.l6.c30.ctg.1	2000	96.9	1	SNP	p	D121N	0	.	.	361	363	GAC	812	814	GAC	142;143;144	G;A;C	119;120;122	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2096	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5192	121.0	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2173	2175	AAT	117;117;117	A;A;T,G	103;104;101,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	342	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1241	82.6	1	SNP	p	V57M	1	.	.	169	171	ATG	633	635	ATG	145;145;145	A;T;G	124;125;124	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
